Waters WAT · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
456.48
-2.06%
Close of 19 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $34.14bn
- Last close × shares
- Volume
- 1m
- Shares, 19 Nov 2026
- Price to earnings
- 43.4
About Waters
From its filings with the US Securities and Exchange Commission
Waters is based in Milford, Massachusetts and is incorporated in Delaware. Its shares trade on NYSE under the ticker WAT. It is a member of the S&P 500. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $3.17bn and net income of $642.6m. At that date it held total assets of $5.08bn and shareholders' equity of $2.56bn.
Waters Corporation (the “Company,” “we,” “our,” or “us”), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving life, materials and food sciences for more than 65 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (“HPLC”), ultra-performance liquid chromatography (“UPLC” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that are frequently employed together (“LC-MS”) and sold as integrated instrument systems using common software platforms.
The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS technology, principally in conjunction with chromatography, is employed in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), nutritional safety analysis and environmental testing.
Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗
How it makes its money
Revenue, year to 31 Dec 2025
- Product [Member] $1.98bn · 62.5%
- Instrument Systems [Member] $1.35bn · 42.5%
- Waters Instrument Systems [Member] $1.10bn · 34.8%
- Waters Service [Member] $1.08bn · 34.1%
Latest on Waters
Our reporting
Next results
Due on 8 Feb 2027. Analysts expect earnings of 4.63 a share.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Waters's ticker?
Waters trades as WAT on its US listing, under ISIN US9418481035.
What was Waters's last closing price?
456.48 on 19 Nov 2026. The figure is in USD and is never converted.
When does Waters next report results?
Results are expected on 8 Feb 2027, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.